Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,624.70
(
-1.36%
)
US TECH 100
23,736.80
(
-1.64%
)
Dow Jones
46,225.15
(
-1.63%
)
Brent Oil
107.94
(
7.24%
)
Bitcoin
71,268.45
(
-3.62%
)
News Focus
News Focus
Post# of 257254
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122793
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: tony111 post# 87560

Tuesday, 12/15/2009 8:36:08 PM

Tuesday, December 15, 2009 8:36:08 PM

Post# of 257254

why did GILD drop their partnership with Achillion?

As mcbio noted, the GILD-ACHN partnership for ACH-1095 (not to be confused with ACH-1625, the drug in the news today) was restructured, not dropped. A relevant piece of background info is that ACH-1095 is a second-generation version of ACH-806, which was discontinued in 2007 due to elevations of creatinine (#msg-18754183).


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Where Real Traders Talk Markets

Join thousands of traders sharing insights, catalysts, and charts.

Join Today